COMMUNIQUÉS West-GlobeNewswire

Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018

02/02/2018 - 14:00

REDWOOD CITY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next generation Pantheris® [...]

Arcturus Therapeutics Appoints Mark Herbert as Interim President

02/02/2018 - 14:00

SAN DIEGO, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today announced that Mark R. Herbert, Vice President of Business Development and Alliance [...]

The American Health Council Appoints Theresa Gutierrez, MSN, RN, FNP to Nursing Board

02/02/2018 - 14:00

NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Theresa Gutierrez, MSN, RN, FNP, has been appointed to the American Health Council’s Nursing Board. Ms. Gutierrez brings an abundance of experience from spending 21 years [...]

PetVivo Holdings, Inc. Approaches Commercial Production

02/02/2018 - 14:00

MINNEAPOLIS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- A long-awaited day is approaching for PetVivo Holdings, Inc. ( www.petvivo.com ) (OTCMARKETS:PETV), an emerging biomedical device company. We are speaking of commercial [...]

Delcath Announces 500th Commercial CHEMOSAT Treatment in Europe

02/02/2018 - 14:00

NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that physicians in Europe [...]

Extendicare Announces Timing of 2017 Fourth Quarter and Year End Results and Conference Call

02/02/2018 - 14:00

MARKHAM, Ontario, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced today that it plans to release its financial results for the fourth quarter and year ended [...]

Kamada to Announce Fiscal Year 2017 Financial Results and Host Conference Call on February 7

02/02/2018 - 14:00

REHOVOT, Israel, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company focused on orphan indications, today announced that it will release financial [...]

Cory Klippsten appointed to Millennium Blockchain Board of Advisors

02/02/2018 - 13:11

Advisor to Top Blockchain Projects, Tech Startups and VCs, formerly of Google, McKinsey and Microsoft LAS VEGAS, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain Inc. (OTC:THCT) (the “Company”) is pleased to [...]

Immunovaccine to Present at 2018 BIO CEO & Investor Conference

02/02/2018 - 13:05

HALIFAX, Nova Scotia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced it will participate in this year’s BIO CEO and Investor [...]

Trevena Promotes Carrie Bourdow to Executive Vice President and Chief Operating Officer

02/02/2018 - 13:00

CHESTERBROOK, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced the promotion of Carrie L. Bourdow from Senior Vice President and Chief Commercial Officer to Executive Vice President [...]

Recro Pharma Announces Key Sales Team Additions

02/02/2018 - 13:00

MALVERN, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]

miRagen Therapeutics Presents New Data from Phase 1 Clinical Trial of MRG-106 in Mycosis Fungoides at the T-Cell Lymphoma Forum

02/02/2018 - 13:00

90% of evaluable patients show clinical improvement in the ongoing Phase 1 clinical trial of MRG-106. 80% of patients treated with 300 mg IV infusion, the anticipated Phase 2 clinical trial dose, demonstrated an [...]

Aixplorer® and Aixplorer® Ultimate Ultrasound Diagnostic Systems Receive 510(k) Clearance for Clinical Management of Liver Disease

02/02/2018 - 12:31

AIX-EN-PROVENCE, France, Feb. 02, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that the Aixplorer® and Aixplorer® [...]

TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab (TG-1101) in Patients with Multiple Sclerosis at the Third Annual ACTRIMS Forum 2018

02/02/2018 - 12:30

100% reduction of T1 Gd-enhancing lesions at week 24 (n=38) 99% median B-cell depletion was observed at week 4 and maintained at week 24 (n=40) TG-1101 was well tolerated across all patients including those receiving 1 [...]

Outcome of Infant Bacterial Therapeutics' rights issue

02/02/2018 - 12:01

Not for release, publication or distribution, directly or indirectly, in or into Australia, Hong Kong, Japan, Canada, Singapore, the United States or in any other jurisdiction where such distribution of this press [...]

Aquinox to Present at LEERINK Partners 7th Annual Global Healthcare Conference

02/02/2018 - 12:00

VANCOUVER, British Columbia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]

Athersys Enters Into New $100 Million Equity Facility with Aspire Capital

02/02/2018 - 12:00

Provides access to capital to support ongoing business and development objectives CLEVELAND, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX ) and Aspire Capital Fund, LLC (“Aspire Capital”) announced [...]

OraSure Technologies Appoints Aradhana Sarin, M.D. to Board of Directors

02/02/2018 - 12:00

BETHLEHEM, Pa., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR ), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Dr. Aradhana [...]

OpGen Announces Pricing of $12 Million Upsized Public Offering

02/02/2018 - 12:00

GAITHERSBURG, Md., Feb. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN ) announces the pricing of a public offering of an aggregate of 3,692,307 units. Each unit is comprised of one share of common stock (or [...]